Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.45 – $2.30
20% from low
Exchange
OTC Link
OS
Borrow rate
1.26%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $43.3M | $128.5M | $476.3M | $821.7M | $842.7M | $770.9M | $724.3M | $667.3M |
| Cost of revenue | $2.8M | $64.5M | $269.6M | $415.3M | $435.7M | $408.5M | $359.9M | $357.6M |
| Gross profit | $40.4M | $64.1M | $206.7M | $406.3M | $407.0M | $329.9M | $364.5M | $309.7M |
| Gross margin | 93.4% | 49.9% | 43.4% | 49.5% | 48.3% | 42.8% | 50.3% | 46.4% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $4.9M | −$34.3M | −$23.5M | −$217.4M | −$84.3M | −$87.8M | $107.3M | $99.1M |
| EBITDA | $9.7M | −$29.5M | $5.2M | −$157.0M | −$10.2M | −$14.6M | $108.8M | $155.8M |
| Net income | −$1.9M | −$43.2M | −$102.2M | −$319.6M | −$212.0M | −$175.5M | −$74.4M | −$137.8M |
| Net margin | -4.4% | -33.6% | -21.5% | -38.9% | -25.2% | -22.8% | -10.3% | -20.6% |
| EPS (diluted) | -0.03 | -0.37 | -0.49 | -1.22 | -0.71 | -0.54 | -0.22 | -0.39 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $654M | $-0.08 | $-0.14–$-0.04 | 2 |
| 2027 | $670M | $-0.01 | $-0.02–$0.00 | 2 |
| 2028 | $676M | $0.07 | $0.07–$0.07 | 1 |
| 2029 | $692M | $0.06 | $0.06–$0.06 | 1 |
Forward consensus · source: Financial Modeling Prep
CRESCO LABS INC
No one on the platform currently holds CRLBF.
No tracked institution reports a position in CRLBF as of their last filing.
No one on the platform has traded CRLBF yet.
| $884 |
| — |
| HLOSFHealios K.K. | $1.80 | +0.00% | $194M | — |
| HUMDFHua Medicine (Shanghai) Ltd. | $0.34 | +0.00% | $339M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 0.4× sales vs its 0.8× historical median P/S.
Fair value ≈ $1.66 · price $0.81 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$CRLBF The DEA and the FDA both say marijuana is safer than alcohol and drugs. WOW! There better be an up tick in pot prices tomorrow!! In my wildest dreams i would have never guessed they would make a comment like that in my life time. Oh dont get me wrong, im buying more pot stocks..
View on StockTwits ↗420 with CNW — Nebraska Allows Grower to Start Medical Cannabis Cultivation $CRLBF $CL.CN https://ibn.fm/APprz #cannabis #Nebraska
View on StockTwits ↗$CRLBF https://www.marijuanamoment.net/dea-and-fda-highlight-how-marijuana-is-safer-than-alcohol-and-opioids-during-rescheduling-hearings-opening-day/ cr
View on StockTwits ↗$CRLBF This flatline (of money or news) will be acquired some day. It's the most plausible future.
View on StockTwits ↗$MSOS https://www.sfgate.com/cannabis/article/glass-house-billion-dollars-22320798.php Remember that a southern California cop founded Glasshouse brands $GLASF . The perfect story and catalyst continues to brew for United States federal marijuana legalization. This was the same company raided by the feds recently when a fleeing worker succumbed to their injuries. Big pharm and big stinky bacco' need pot stocks beaten down for favorable acquisition/hostile take over numbers. Cannabis > alcohol & tobacco Don't forget $CRLBF and $VRNO these are beaten down operators trading at book value with explosive upside potential.
View on StockTwits ↗$CRLBF would like to see a buyout offer by a Big Alcohol Company __ need a nice CASH Infusion if you know what I mean?
View on StockTwits ↗$CRLBF positive momentum heading into Mondays hearings. Any good news comes out and we will see a small jump. This stock is at rock bottom just ahead of major news. Its nuts.
View on StockTwits ↗$CRLBF, maybe some movement on rescheduling in the next couple of week? https://www.marijuanamoment.net/dea-judge-sets-testimony-schedule-for-marijuana-rescheduling-hearing-starting-next-week/
View on StockTwits ↗$CRLBF Some interesting Cresco speculation swirling around on Twitter: https://x.com/ShillOfWeedST/status/2069084187697594551
View on StockTwits ↗$CRLBF C'mon pumpers we need some entertainment
View on StockTwits ↗$CRLBF Is this frikn dog of a stock annoying me on purpose or what ?
View on StockTwits ↗$GTBIF $CURLD $TRLV $CRLBF $GLASF the only way I see the DEA move all of Cannabis to S3 is if 100% DJT told Terry Cole to do it and he obeyed his orders __ you think?
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.